The European Commission authorised, on Monday (21 December), the use of the Covid-19 vaccine jointly developed by Pfizer and BioNTech, paving the way for member states to start vaccination programmes within the next few days.
The move came hours after the European Medicine Agency (EMA) issued a positive scientific assessment, recommending conditional marketing authorisation for the vaccine known by the brand-name Comirnaty.
Comirnaty will be given as two injections into the arm, a...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? LoginElena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.
Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.